Participants
autoimmune, degenerative or genetic diseases, allergies
ALLERGIES
Participants were eligible for the study if they were born female, aged 15–20 years old inclusive, were sexually active with one to five sexual partners reported in their lifetime, and planned to reside in the study area for 37 months. The exclusion criteria were people living with HIV for whom few data on single-dose HPV VE are available, history of previous HPV vaccination, allergies to vaccine components of latex, pregnancy, hysterectomy, history of autoimmune, degenerative or genetic diseases, and investigator discretion regarding participant safety. Sex assigned at birth was assessed through participant self-report at screening. Participants were recruited through community outreach. All participants, and their parents/guardians in the case of minors, provided written informed consent, which included counseling about randomization, risks and benefits of participation, study procedures and their rights as research participants.